FDG-PET as a pre-operative biomarker for predicting and optimizing response to subcallosal cingulate area deep brain stimulation.
Journal:
Biological psychiatry
Published Date:
May 20, 2025
Abstract
BACKGROUND: Deep brain stimulation targeting the subcallosal cingulate area (SCC-DBS) has emerged as a promising therapy for treatment-resistant depression (TRD). However, only half to two thirds of patients experience meaningful clinical response, highlighting the need for biomarkers that could help to optimize SCC-DBS outcomes. Our group previously showed that a support vector machine (SVM) incorporating pre-operative FDG-PET glucose metabolism values from frontal pole, anterior cingulate cortex, and temporal pole could retrospectively classify treatment response in 21 TRD patients with 81.0% accuracy. Here, we assessed the out-of-sample performance and wider applicability of this putative biomarker.
Authors
Keywords
No keywords available for this article.